Stay updated on XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial page.

Latest updates to the XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial page
- Check6 days agoChange DetectedA new version on 2026-02-17 adds the latest Study Status, and version 33 is recorded on 2026-02-12. The 2025-11-17 version was deleted.SummaryDifference0.3%

- Check13 days agoChange DetectedAdministrative site updates: revision v3.4.2 was added and the government funding notice and Revision: v3.4.1 were removed; these changes are UI-level and do not affect study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check21 days agoChange DetectedA site-wide funding notice was added, warning that information may not be up to date, and the page now shows a new site revision tag (v3.4.1) replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check28 days agoChange DetectedUI updates add a glossary toggle and color-coded change highlights (green for additions, red for deletions) with an updated revision label (v3.4.0). The wording around No FEAR Act Data and the Revision label was updated from v3.3.4 to reflect the new version; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check42 days agoChange DetectedThe page footer shows a revision bump from v3.3.3 to v3.3.4, a minor internal update with no impact on study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer.SummaryDifference0.1%

Stay in the know with updates to XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial page.